PBYI

Puma Biotechnology (PBYI)

Puma Biotechnology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PBYI

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/14	10 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/06/14	10 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/06/14	10 : 43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/06/14	10 : 41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/06/08	06 : 37	Business Wire	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PBYI	Puma Biotechnology Inc
2024/06/04	03 : 33	Business Wire	Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer	NASDAQ:PBYI	Puma Biotechnology Inc
2024/06/02	23 : 01	Business Wire	Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)	NASDAQ:PBYI	Puma Biotechnology Inc
2024/05/28	22 : 00	Business Wire	Puma Biotechnology to Join Russell 3000 Index	NASDAQ:PBYI	Puma Biotechnology Inc
2024/05/24	06 : 15	Business Wire	Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting	NASDAQ:PBYI	Puma Biotechnology Inc
2024/05/18	05 : 43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBYI	Puma Biotechnology Inc
2024/05/03	05 : 05	Business Wire	Puma Biotechnology Reports First Quarter Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/04/19	05 : 15	Business Wire	Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/04/04	06 : 30	Business Wire	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PBYI	Puma Biotechnology Inc
2024/03/20	21 : 30	Business Wire	Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	NASDAQ:PBYI	Puma Biotechnology Inc
2024/03/01	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBYI	Puma Biotechnology Inc
2024/03/01	06 : 05	Business Wire	Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/28	08 : 30	Business Wire	Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/23	06 : 10	Business Wire	Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/16	06 : 10	Business Wire	Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	08 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/15	07 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/14	22 : 19	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/13	22 : 30	Business Wire	Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer	NASDAQ:PBYI	Puma Biotechnology Inc
2024/02/07	05 : 54	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/18	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/12	06 : 07	Business Wire	Puma Biotechnology to Present at B. Riley Securities 4th Annual Oncology Conference	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/11	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBYI	Puma Biotechnology Inc
2024/01/11	06 : 38	Edgar (US Regulatory)	Form 144/A - Report of proposed sale of securities: [Amend]	NASDAQ:PBYI	Puma Biotechnology Inc